alimad wrote:
Alonso : the introduction of a new drug into the
marketplace should be contingent upon our having a good understanding of its social impact. However, the social impact of the newly marketed antihistamine is far from clear. It is obvious, then, that there should be a general reduction in the pace of bringing to the
marketplace new drugs that are now being created.
Which of the following, if true, most strengthens the argument?
The social impact of the new antihistamine is much better understood than that of the most new drugs being tested.
The social impact of some of the new drugs being tested is poorly understood.
The economic success of some drugs is inversely proportional to how well we understand their social impact.
The new antihistamine is chemically similar to some of the new drugs being tested.
The new antihistamine should be next on the market only if most new drugs being tested should be on the market also..
Please provide feedback.
Thanks
Conclusion: Pace of new drugs brought to market should be slowed. In the argument there is a gap - the conclusion is based on the premise that the "social impact of the newly marketed
antihistamine is far from clear"
A. Weakens the argument
B. Sounds Plausible, however it is not attacking the conclusion and does not talk about antihistamines
C.Not attacking the conclusion and does not talk about antihistamines
D. If the new atihistamine is not well understood and is similar to the new drug being tested, then it implies that the new drugs being tested are not well understood either. Thus the answer.
E. New antihistamine is already on the market also what is the gurantee that the new drugs will be well understood before introduction into the
marketplace.
close
